COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1700: Articles 16991-17000  | Next

Management of COVID-19-related Arterial Thrombosis Leading to Acute Limb-threatening Ischemia
raza, w., ehsan, o.
10.1101/2021.03.20.21252888 — Posted: 2021-03-24
Economic Crisis and Mental Health during the COVID-19 Pandemic in Japan
Matsubayashi, T., Ishikawa, Y., Ueda, M.
10.1101/2021.03.20.21254038 — Posted: 2021-03-24
Dimeric form of SARS-CoV-2 polymerase
Jochheim, F. A., Tegunov, D., Hillen, H. S., Schmitzova, J., Kokic, G., Dienemann, C., Cramer, P.
10.1101/2021.03.23.436644 — Posted: 2021-03-24
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs
Yazdani, S., De Maio, N., Ding, Y., Shahani, V., Goldman, N., Schapira, M.
10.1101/2021.03.23.436637 — Posted: 2021-03-23
Clonal dissection of immunodominance and cross-reactivity of the CD4+ T cell response to SARS-CoV-2
Low, J. S., Vaqueirinho, D., Mele, F., Foglierini, M., Perotti, M., Jarrossay, D., Jovic, S., Terrot, T., Franzetti Pellanda, A., Biggiogero, M., Garzoni, C., Ferrari, P., Ceschi, A., Lanzavecchia, A., Cassotta, A., Sallusto, F.
10.1101/2021.03.23.436642 — Posted: 2021-03-23
Identification, crystallization and epitope determination of public TCR shared and expanded in COVID-19 patients
Lu, X., Hosono, Y., Ishizuka, S., Nagae, M., Ishikawa, E., Motooka, D., Ozaki, Y., Sax, N., Shinnakasu, R., Inoue, T., Onodera, T., Matsumura, T., Shinkai, M., Sato, T., Nakamura, S., Mori, S., Kanda, T., Nakayama, E. E., Shioda, T., Kurosaki, T., Arase, H., Yamashita, K., Takahashi, Y., Yamasaki, S.
10.1101/2021.03.23.436573 — Posted: 2021-03-23
Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers
Riahi, S., Lee, J. H., Wei, S., Cost, R., Masiero, A., Prades, C., Olfati-Saber, R., Wendt, M., Park, A., Qiu, Y., Zhou, Y.
10.1101/2021.03.23.436613 — Posted: 2021-03-23
Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody domains
Sun, Z., Kim, A., Sobolewski, M. D., Enick, N., Chen, C., Adams, C., Jacobs, J. L., McCormick, K. D., Mellors, J. W., Dimitrov, D. S., Li, W.
10.1101/2021.03.22.436481 — Posted: 2021-03-23
Dry Swab Method of sample collection for SARS-CoV2 testing can be used for culturing virus
Ram, S., Enayathullah, M. G., Parekh, Y., Tallapaka, K. B., Mishra, R. K., Kiran Kumar, B.
10.1101/2021.03.23.436593 — Posted: 2021-03-23
Characterization and functional interrogation of SARS-CoV-2 RNA interactome
Labeau, A., Lefevre-Utile, A., Bonnet-Madin, L., Fery-Simonian, L., Soumelis, V., Lotteau, V., Vidalain, P.-O., Amara, A., Meertens, L.
10.1101/2021.03.23.436611 — Posted: 2021-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).